Tumour-Effector Cell Avidity is a Key Driver for Cellular Therapy Efficacy

Time: 11:30 am
day: Day 1 - Track A - Morning


  • Avidity is a new key parameter for predicting T-cell function
  • Avidity data strongly correlates to in vitro functional assays and preclinical mouse studies
  • The z-Movi Cell Avidity Analyzer measures the avidity of lymphocytes with tumour cells at the single-cell level using an extremely quick and easy workflow